May 2018

FIRST AUSTRALIAN TRIAL TO EXPLORE EFFECTS OF MEDICINAL CANNABIS ON INSOMNIA

Researchers at the University of Western Australia (UWA) are hoping the sedation effect brought on by medicinal cannabis could be an alternative to current drugs on the market and will be the first ones to test an oil containing cannabis on patients suffering with chronic sleeping issues.

UWA study lead, Professor Peter Eastwood said, ‘If it is as safe as people hope, if it works as well as people hope, then it could be a game changer, not just for insomnia, but for a bunch of health problems.’

Read the article here.

 

One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.

READ MORE >

In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.

READ MORE >

What’s most important in business – purpose or profit? At ANTG we get to achieve both.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >